purified human c3a (Merck & Co)
Structured Review
Purified Human C3a, supplied by Merck & Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/purified+human+c3a/purify+human+c3a/pm34454293-46-1-6
Average 90 stars, based on 1 article reviews
Images
Related Articles
Purification:Article Title: Anaphylatoxin receptor promiscuity for commonly used complement C5a peptide agonists. Article Snippet: The complement system is an essential component of innate immunity.. Its activation generates the effector cleavage proteins, anaphylatoxins C3a and C5a, that exert activity by interacting with three structurally related seven-transmembrane receptors.. C3a activates C3aR, whilst C5a interacts with both C5aR1 and C5aR2 with equal potency. Article Title: The “C3aR Antagonist” SB290157 is a Partial C5aR2 Agonist Article Snippet: The C3aR inhibitor, SB290157 trifluoroacetate salt, and purified Article Title: The "C3aR Antagonist" SB290157 is a Partial C5aR2 Agonist. Article Snippet: The C3aR inhibitor, SB290157 trifluoroacetate salt, and purified Article Title: The ‘C3aR antagonist’ SB290157 is a partial C5aR2 agonist Article Snippet: The C3aR inhibitor, SB290157 trifluoroacetate salt, and purified Transfection:Article Title: Anaphylatoxin receptor promiscuity for commonly used complement C5a peptide agonists. Article Snippet: The complement system is an essential component of innate immunity.. Its activation generates the effector cleavage proteins, anaphylatoxins C3a and C5a, that exert activity by interacting with three structurally related seven-transmembrane receptors.. C3a activates C3aR, whilst C5a interacts with both C5aR1 and C5aR2 with equal potency. Article Title: The “C3aR Antagonist” SB290157 is a Partial C5aR2 Agonist Article Snippet: The C3aR inhibitor, SB290157 trifluoroacetate salt, and purified Article Title: The "C3aR Antagonist" SB290157 is a Partial C5aR2 Agonist. Article Snippet: The C3aR inhibitor, SB290157 trifluoroacetate salt, and purified Article Title: The ‘C3aR antagonist’ SB290157 is a partial C5aR2 agonist Article Snippet: The C3aR inhibitor, SB290157 trifluoroacetate salt, and purified Derivative Assay:Article Title: Anaphylatoxin receptor promiscuity for commonly used complement C5a peptide agonists. Article Snippet: The complement system is an essential component of innate immunity.. Its activation generates the effector cleavage proteins, anaphylatoxins C3a and C5a, that exert activity by interacting with three structurally related seven-transmembrane receptors.. C3a activates C3aR, whilst C5a interacts with both C5aR1 and C5aR2 with equal potency. Article Title: The “C3aR Antagonist” SB290157 is a Partial C5aR2 Agonist Article Snippet: The C3aR inhibitor, SB290157 trifluoroacetate salt, and purified Article Title: The "C3aR Antagonist" SB290157 is a Partial C5aR2 Agonist. Article Snippet: The C3aR inhibitor, SB290157 trifluoroacetate salt, and purified Article Title: The ‘C3aR antagonist’ SB290157 is a partial C5aR2 agonist Article Snippet: The C3aR inhibitor, SB290157 trifluoroacetate salt, and purified |


